🇮🇳 Ajanta Pharma Limited
Forum topic · AJANTPHARM.BO · Company page: financials, ownership and filings
Join the discussion on Ajanta Pharma Limited
Loading…
Mutual funds: 88 funds hold $394 million
88 mutual funds in 2 countries hold shares of Ajanta Pharma Limited worth $394 million, about 8.2% of the company (funds' newest reports, up to 31 October 2026).
Since their previous reports 29 funds added shares and 13 sold; on balance they sold $8 million. Share splits are not counted as trading.
Product recall: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Drugs (FDA) published a recall by Ajanta Pharma USA Inc on 17 September 2026: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02.
Reason: Failed Dissolution Specifications: below specification
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.